ABG Sundal Collier leads Oncoinvent NOK 149 million private placement at NOK 90 per share

• ABG Sundal Collier Holding ASA acted as joint global coordinator, joint bookrunner for Oncoinvent’s NOK 149 million equity raise.
• Oncoinvent completed a private placement, retail offering on Sept. 22, 2026; issued 1,650,000 new shares at NOK 90.
• Proceeds target Phase 2 progress toward an interim readout in March/April 2027, regulatory alignment, Phase 3 IND/CTA preparation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABG Sundal Collier Holding ASA published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.